Gilberto de Lima Lopes, Jr., MD, MBA, FAMS, FASCO

As the world faced the threat of a novel respiratory pathogen, SARS-CoV-2, in the first months of 2020, there was a great deal of uncertainty about its effect on people, especially those living with a diagnosis of cancer.